Progesterone: The Oldest "New" Drug to Nearly Reach the Market
There is a certain comfort that comes from prescribing an approved drug for its FDA-indicated purpose. However, the most exciting news in preterm birth prevention resulted from two studies published in 2003 using compounded progesterone. Since then, the involvement of Pharma and the FDA seems only to have undermined patient care.
progesterone old new drug nearly reach market certain comfort come prescribe approve drug fda indicate purpose exciting news preterm birth prevention result study publish compound progesterone involvement pharma fda undermine patient care